The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial

Surviving Sepsis Campaign

(2013) R. Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

(2013) Steven M. Opal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Improving clinical trials in the critically ill

(2010) Derek C. Angus et al.   CRITICAL CARE MEDICINE

The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis*

(2010) Mitchell M. Levy et al.   CRITICAL CARE MEDICINE

Endotoxin removal devices for the treatment of sepsis and septic shock

(2010) B Davies et al.   LANCET INFECTIOUS DISEASES

Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial

(2009) R Phillip Dellinger et al.   CRITICAL CARE MEDICINE

International Differences in the Treatment of Sepsis

(2009) John A. Kellum et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock

(2009) Dinna N. Cruz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Toward theragnostics

(2008) Frédéric Pene et al.   CRITICAL CARE MEDICINE